🤯 Have you seen our AI stock pickers’ 2024 results? 84.62%! Grab November’s list now.Pick Stocks with AI

Alnylam Pharmaceuticals Inc (ALNY)

NASDAQ
Currency in USD
273.91
+7.32(+2.75%)
Closed
After Hours
270.00-3.91(-1.43%)

ALNY Income Statement

Advanced Income Statement
Period Ending:
2014
31/12
2015
31/12
2016
31/12
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
Total Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa219.75492.85844.291,037.421,828.29
Total Revenues Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+193.36%+124.28%+71.31%+22.88%+76.23%
Cost Of Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa25.0678.05140.14168.82310.41
Gross Profit
aa.aaaa.aaaa.aaaa.aaaa.aa194.69414.8704.14868.61,517.89
Gross Profit Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+166.31%+113.06%+69.75%+23.36%+74.75%
Gross Profit Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa88.6%84.16%83.4%83.73%83.02%
Other Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa1,134.121,243.241,412.81,653.671,800.06
Other Operating Expenses, Total Growth
R&D Expenses
Selling General & Admin Expenses
Other Operating Expenses
aa.aaaa.aaaa.aaaa.aaaa.aa+27.75%+9.62%+13.64%+17.05%+8.85%
aa.aaaa.aaaa.aaaa.aaaa.aa600.46654.82792.16883.021,004.42
aa.aaaa.aaaa.aaaa.aaaa.aa533.66588.42620.64770.66795.65
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Operating Income
aa.aaaa.aaaa.aaaa.aaaa.aa-939.43-828.44-708.65-785.07-282.18
Operating Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-15.31%+11.81%+14.46%-10.78%+64.06%
EBIT Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa-427.5%-168.09%-83.93%-75.68%-15.43%
Net Interest Expenses
aa.aaaa.aaaa.aaaa.aaaa.aa33.45-72.69-141.44-131.16-25.66
Net Interest Expenses Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+14.31%-317.31%-94.59%+7.27%+80.44%
Interest Expense, Total
aa.aaaa.aaaa.aaaa.aaaa.aa--84.5-143.02-155.97-121.22
Interest And Investment Income
aa.aaaa.aaaa.aaaa.aaaa.aa33.4511.811.5824.8195.56
Other Non Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa9.44-8.52-57.75-100.86-108.74
EBT, Excl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa-896.54-909.64-907.84-1,017.1-416.57
Gain (Loss) On Sale Of Assets
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Other Unusual Items, Total
aa.aaaa.aaaa.aaaa.aaaa.aa----76.59-
EBT, Incl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa-885.25-855.6-852.14-1,126.99-433.52
EBT, Incl. Unusual Items Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-16.38%+3.35%+0.4%-32.25%+61.53%
EBT, Incl. Unusual Items Margin
aa.aaaa.aaaa.aaaa.aaaa.aa-402.85%-173.6%-100.93%-108.63%-23.71%
Income Tax Expense
aa.aaaa.aaaa.aaaa.aaaa.aa0.862.680.684.166.73
Net Income to Company
aa.aaaa.aaaa.aaaa.aaaa.aa-886.12-858.28-852.82-1,131.16-440.24
Minority Interest
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Net Income
aa.aaaa.aaaa.aaaa.aaaa.aa-886.12-858.28-852.82-1,131.16-440.24
Net Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-16.37%+3.14%+0.64%-32.64%+61.08%
Net Income Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa-403.24%-174.15%-101.01%-109.04%-24.08%
Preferred Dividend and Other Adjustments
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Net Income to Common Excl. Extra Items
aa.aaaa.aaaa.aaaa.aaaa.aa-886.12-858.28-852.82-1,131.16-440.24
Basic EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa-8.11-7.46-7.2-9.3-3.52
Basic EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-7.13%+7.96%+3.54%-29.11%+62.08%
Diluted EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa-8.11-7.46-7.2-9.3-3.52
Diluted EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-7.13%+7.96%+3.54%-29.17%+62.1%
Basic Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa109.26114.99118.45121.69124.91
Diluted Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa109.26114.99118.45121.69124.91
Dividend Per Share
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Dividend Per Share Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-----
EBITDA
aa.aaaa.aaaa.aaaa.aaaa.aa-922.26-793.67-661.09-740.6-228.12
EBITDA Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-15.36%+13.94%+16.7%-12.03%+69.2%
EBITDA Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa-419.68%-161.04%-78.3%-71.39%-12.48%
EBIT
aa.aaaa.aaaa.aa